Role of HPV DNA testing in modern gynaecological practice

Guglielmo Ronco, Paolo Giorgi Rossi

Research output: Contribution to journalReview article

Abstract

The identification of some types of human papillomavirus (HPV) as necessary, but not sufficient, cause of cervical cancer has suggested the use of HPV testing in cervical cancer prevention. A large number of studies has provided evidence supporting its application (1) as primary screening test, (2) for triaging borderline cytology, (3) for follow-up after positive primary test but no abnormal histology and (4) as a test of cure. They also allowed a reasonably good definition of the appropriate policies and protocols, leading to the delivery of evidence-based guidelines resulting from a systematic review of the literature. In this chapter, we present a critical analysis of the recommendations of the main European and North American guidelines relative to industrialised countries.

Original languageEnglish
Pages (from-to)107-118
Number of pages12
JournalBest Practice and Research: Clinical Obstetrics and Gynaecology
Volume47
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

Uterine Cervical Neoplasms
Guidelines
Forensic Anthropology
DNA
Developed Countries
Cell Biology
Histology

Keywords

  • Cervical cancer
  • Follow-up
  • Human papillomavirus
  • Primary test
  • Screening
  • Test of cure

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Role of HPV DNA testing in modern gynaecological practice. / Ronco, Guglielmo; Giorgi Rossi, Paolo.

In: Best Practice and Research: Clinical Obstetrics and Gynaecology, Vol. 47, 01.02.2018, p. 107-118.

Research output: Contribution to journalReview article

@article{d6289355e1834960964da27545df3e72,
title = "Role of HPV DNA testing in modern gynaecological practice",
abstract = "The identification of some types of human papillomavirus (HPV) as necessary, but not sufficient, cause of cervical cancer has suggested the use of HPV testing in cervical cancer prevention. A large number of studies has provided evidence supporting its application (1) as primary screening test, (2) for triaging borderline cytology, (3) for follow-up after positive primary test but no abnormal histology and (4) as a test of cure. They also allowed a reasonably good definition of the appropriate policies and protocols, leading to the delivery of evidence-based guidelines resulting from a systematic review of the literature. In this chapter, we present a critical analysis of the recommendations of the main European and North American guidelines relative to industrialised countries.",
keywords = "Cervical cancer, Follow-up, Human papillomavirus, Primary test, Screening, Test of cure",
author = "Guglielmo Ronco and {Giorgi Rossi}, Paolo",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.bpobgyn.2017.08.002",
language = "English",
volume = "47",
pages = "107--118",
journal = "Best Practice and Research in Clinical Obstetrics and Gynaecology",
issn = "1521-6934",
publisher = "Bailliere Tindall Ltd",

}

TY - JOUR

T1 - Role of HPV DNA testing in modern gynaecological practice

AU - Ronco, Guglielmo

AU - Giorgi Rossi, Paolo

PY - 2018/2/1

Y1 - 2018/2/1

N2 - The identification of some types of human papillomavirus (HPV) as necessary, but not sufficient, cause of cervical cancer has suggested the use of HPV testing in cervical cancer prevention. A large number of studies has provided evidence supporting its application (1) as primary screening test, (2) for triaging borderline cytology, (3) for follow-up after positive primary test but no abnormal histology and (4) as a test of cure. They also allowed a reasonably good definition of the appropriate policies and protocols, leading to the delivery of evidence-based guidelines resulting from a systematic review of the literature. In this chapter, we present a critical analysis of the recommendations of the main European and North American guidelines relative to industrialised countries.

AB - The identification of some types of human papillomavirus (HPV) as necessary, but not sufficient, cause of cervical cancer has suggested the use of HPV testing in cervical cancer prevention. A large number of studies has provided evidence supporting its application (1) as primary screening test, (2) for triaging borderline cytology, (3) for follow-up after positive primary test but no abnormal histology and (4) as a test of cure. They also allowed a reasonably good definition of the appropriate policies and protocols, leading to the delivery of evidence-based guidelines resulting from a systematic review of the literature. In this chapter, we present a critical analysis of the recommendations of the main European and North American guidelines relative to industrialised countries.

KW - Cervical cancer

KW - Follow-up

KW - Human papillomavirus

KW - Primary test

KW - Screening

KW - Test of cure

UR - http://www.scopus.com/inward/record.url?scp=85029212588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029212588&partnerID=8YFLogxK

U2 - 10.1016/j.bpobgyn.2017.08.002

DO - 10.1016/j.bpobgyn.2017.08.002

M3 - Review article

AN - SCOPUS:85029212588

VL - 47

SP - 107

EP - 118

JO - Best Practice and Research in Clinical Obstetrics and Gynaecology

JF - Best Practice and Research in Clinical Obstetrics and Gynaecology

SN - 1521-6934

ER -